Skip to main content
Erschienen in: Obesity Surgery 1/2010

01.01.2010 | Clinical Research

Non-transectional Open Gastric Bypass as the Definitive Bariatric Procedure for 61 Patients with BMI of 70 and Higher

verfasst von: Gus J. Slotman

Erschienen in: Obesity Surgery | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Technical difficulties in laparoscopic gastric bypass for severely obese patients have led to sleeve gastrectomy first and then laparoscopic gastric bypass as a second stage after significant weight loss. Rather than commit these fragile patients to two operations, we have done open gastric bypass as a definitive surgical treatment for extreme obesity.

Methods

Office records of 61 patients with body mass index (BMI) of 70 and higher were reviewed. All underwent non-transectional open gastric bypass with a 150 cm Roux limb. Data included age, sex, weight, BMI, co-morbidities, operative information, length of stay (LOS), surgical morbidity, and percent excess weight loss (%XSWL). Data are in median (range).

Results

There were 21 (34%) men and 40 (66%) women: age, 37 years (19–53); pre-operative weight, 468 lb (300–650); and pre-operative BMI, 77 (70–95). Co-morbidities were diabetes mellitus, 26 (46%); hypertension, 26 (43%); sleep apnea, 61 (100%); gastroesophageal reflux disease, 20 (33%); and hypothyroid nine (15%). Incision length was 15 cm (12–20), abdominal wall fat thickness was 8 cm (5–13), operative time was 150 min (100–210), and estimated blood loss was 100 ml (25–750); post-op intensive care unit: yes 16 (26%) and no 44 (74%). LOS was 3 days for 44 patients (74%), 4 days for 11 (18%), 5 days for five (8%), and 7 days for one (1.6%). Post-operative morbidity was as follows: zero mortality, splenectomy, stoma leak, deep venous thrombosis, pulmonary embolus, GI bleeding, stomal ulcer, intestinal obstruction, fascial dehiscence, or 30-day readmission; wound infections in one (1.6%); skin wound separation in six (10%); pneumonia in one (1.6%); anemia in nine (14.8%); vitamin B12 deficiency in six (10%); incisional hernia in 17 (28%); and gastric staple line disruption in two (3.3%). %XSWL were 51% in 1 year (28–84) and 60% in 2 years (27–97).

Conclusions

Non-transectional open gastric bypass for patients with BMI of 70 and higher is safe and effective as a one-stage operation for severe obesity.
Literatur
1.
Zurück zum Zitat Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.CrossRefPubMed Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.CrossRefPubMed
2.
Zurück zum Zitat Sjostrom L, Narbro K, Sjostrom C, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.CrossRefPubMed Sjostrom L, Narbro K, Sjostrom C, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.CrossRefPubMed
3.
Zurück zum Zitat Mittermair RP, Aigner F, Nehoda H. Results and complications after laparoscopic adjustable gastric banding in super-obese patients, using the Swedish Band. Obes Surg. 2004;14:1327–30.CrossRefPubMed Mittermair RP, Aigner F, Nehoda H. Results and complications after laparoscopic adjustable gastric banding in super-obese patients, using the Swedish Band. Obes Surg. 2004;14:1327–30.CrossRefPubMed
4.
Zurück zum Zitat Hamed O, Kerlakian G, Engel A, et al. Outcome of hand-assisted laparoscopic gastric bypass in super obese patients. SOARD. 2008;4:618–24. Hamed O, Kerlakian G, Engel A, et al. Outcome of hand-assisted laparoscopic gastric bypass in super obese patients. SOARD. 2008;4:618–24.
5.
Zurück zum Zitat Artuso D, Wayne M, Ashutosh K, et al. Extremely high body mass index is not a contraindication to laparoscopic gastric bypass. Obes Surg. 2004;14:750–4.CrossRefPubMed Artuso D, Wayne M, Ashutosh K, et al. Extremely high body mass index is not a contraindication to laparoscopic gastric bypass. Obes Surg. 2004;14:750–4.CrossRefPubMed
6.
Zurück zum Zitat Stephens DJ, Saunders JK, Belsley S, et al. Short-term outcomes for super-obese (BMI > 60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass. SOARD. 2008;4:408–15. Stephens DJ, Saunders JK, Belsley S, et al. Short-term outcomes for super-obese (BMI > 60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass. SOARD. 2008;4:408–15.
7.
Zurück zum Zitat Tichansky DS, DeMaria EJ, Fernandez AZ, et al. Postoperative complications are not increased in super-super obese patients who undergo laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2005;19:939–41.CrossRefPubMed Tichansky DS, DeMaria EJ, Fernandez AZ, et al. Postoperative complications are not increased in super-super obese patients who undergo laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2005;19:939–41.CrossRefPubMed
8.
Zurück zum Zitat Farkas DT, Vemulapalli P, Haider A, et al. Laparoscopic Roux-en-Y gastric bypass is safe and effective in patients with a BMI > 60. Obes Surg. 2005;15:486–93.CrossRefPubMed Farkas DT, Vemulapalli P, Haider A, et al. Laparoscopic Roux-en-Y gastric bypass is safe and effective in patients with a BMI > 60. Obes Surg. 2005;15:486–93.CrossRefPubMed
9.
Zurück zum Zitat Gould JC, Garren MJ, Boll V, et al. Laparoscopic gastric bypass: risks vs. benefits up to two years following surgery in super-super obese patients. Surgery. 2006;140(4):524–9.CrossRefPubMed Gould JC, Garren MJ, Boll V, et al. Laparoscopic gastric bypass: risks vs. benefits up to two years following surgery in super-super obese patients. Surgery. 2006;140(4):524–9.CrossRefPubMed
10.
Zurück zum Zitat Abeles D, Kim JJ, Tarnoff ME, et al. Primary laparoscopic gastric bypass can be performed safely in patients with BMI > 60. J Am Coll Surg. 2009;208(2):236–40.CrossRefPubMed Abeles D, Kim JJ, Tarnoff ME, et al. Primary laparoscopic gastric bypass can be performed safely in patients with BMI > 60. J Am Coll Surg. 2009;208(2):236–40.CrossRefPubMed
11.
Zurück zum Zitat Taylor JD, Leitman M, Hon P, et al. Outcome and complications of gastric bypass in super-super obesity versus morbid obesity. Obes Surg. 2006;16:16–8.CrossRefPubMed Taylor JD, Leitman M, Hon P, et al. Outcome and complications of gastric bypass in super-super obesity versus morbid obesity. Obes Surg. 2006;16:16–8.CrossRefPubMed
12.
Zurück zum Zitat Torchia F, DiMaro A, Rosano P, et al. Lapband system in super-superobese patients (>60 kg/m2): 4-year results. Obes Surg. 2009;19:1211–5.CrossRefPubMed Torchia F, DiMaro A, Rosano P, et al. Lapband system in super-superobese patients (>60 kg/m2): 4-year results. Obes Surg. 2009;19:1211–5.CrossRefPubMed
13.
Zurück zum Zitat Fielding GA. Laparoscopic adjustable gastric banding for massive superobesity (>60 body mass index kg/m2). Surg Endosc. 2003;17:1541–5.CrossRefPubMed Fielding GA. Laparoscopic adjustable gastric banding for massive superobesity (>60 body mass index kg/m2). Surg Endosc. 2003;17:1541–5.CrossRefPubMed
14.
Zurück zum Zitat Bowne WB, Julliard K, Castro AE, et al. Laparoscopic gastric bypass is superior to adjustable gastric band in super morbidly obese patients. Arch Surg. 2006;141:683–9.CrossRefPubMed Bowne WB, Julliard K, Castro AE, et al. Laparoscopic gastric bypass is superior to adjustable gastric band in super morbidly obese patients. Arch Surg. 2006;141:683–9.CrossRefPubMed
15.
Zurück zum Zitat Sanchez-Santos R, Vilarrasa N, Pujol J, et al. Is Roux-en-Y gastric bypass adequate in the super-obese? Obes Surg. 2006;16:478–83.CrossRefPubMed Sanchez-Santos R, Vilarrasa N, Pujol J, et al. Is Roux-en-Y gastric bypass adequate in the super-obese? Obes Surg. 2006;16:478–83.CrossRefPubMed
16.
Zurück zum Zitat Kreitz K, Rovito PF. Laparoscopic Roux-en-Y gastric bypass in the “Megaobese”. Arch Surg. 2003;138:707–9.CrossRefPubMed Kreitz K, Rovito PF. Laparoscopic Roux-en-Y gastric bypass in the “Megaobese”. Arch Surg. 2003;138:707–9.CrossRefPubMed
17.
Zurück zum Zitat Brolin RE. Invited critique of laparoscopic Roux-en-Y gastric bypass in the “Megaobese”. Arch Surg. 2003;138:710.CrossRef Brolin RE. Invited critique of laparoscopic Roux-en-Y gastric bypass in the “Megaobese”. Arch Surg. 2003;138:710.CrossRef
18.
Zurück zum Zitat Sowemimo OA, Yood SM, Courtney J, et al. Natural history of morbid obesity without surgical intervention. SOARD. 2007;3:73–7. Sowemimo OA, Yood SM, Courtney J, et al. Natural history of morbid obesity without surgical intervention. SOARD. 2007;3:73–7.
20.
Zurück zum Zitat Fuks D, Verhaeghe P, Brehant O, et al. Results of laparoscopic sleeve gastrectomy: a prospective study in 135 patients with morbid obesity. Surgery. 2009;145(1):106–13.CrossRefPubMed Fuks D, Verhaeghe P, Brehant O, et al. Results of laparoscopic sleeve gastrectomy: a prospective study in 135 patients with morbid obesity. Surgery. 2009;145(1):106–13.CrossRefPubMed
21.
Zurück zum Zitat Regan JP, Inabnet WB, Gagner M, et al. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;13:861–4.CrossRefPubMed Regan JP, Inabnet WB, Gagner M, et al. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;13:861–4.CrossRefPubMed
22.
Zurück zum Zitat Cottam D, Qureshi G, Mattar G, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc. 2006;20:859–63.CrossRefPubMed Cottam D, Qureshi G, Mattar G, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc. 2006;20:859–63.CrossRefPubMed
23.
Zurück zum Zitat Brolin RE. Prospective, randomized evaluation of midline fascial closure in gastric bariatric operations. Am J Surg. 1996;182:328–31.CrossRef Brolin RE. Prospective, randomized evaluation of midline fascial closure in gastric bariatric operations. Am J Surg. 1996;182:328–31.CrossRef
24.
Zurück zum Zitat Sugerman HJ, Brewer WH, Shiffman ML, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg. 1995;169:91–7.CrossRefPubMed Sugerman HJ, Brewer WH, Shiffman ML, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg. 1995;169:91–7.CrossRefPubMed
25.
Zurück zum Zitat Dresel A, Kuhn JA, McCarty TM. Laparoscopic roux-en-Y gastric bypass in morbidly obese and super morbidly obese patients. Am J Surg. 2004;187:230–2.CrossRefPubMed Dresel A, Kuhn JA, McCarty TM. Laparoscopic roux-en-Y gastric bypass in morbidly obese and super morbidly obese patients. Am J Surg. 2004;187:230–2.CrossRefPubMed
26.
Zurück zum Zitat American Society for Metabolic and Bariatric Surgery. Position statement: sleeve gastrectomy as a bariatric procedure. SOARD. 2007;3:573–6. American Society for Metabolic and Bariatric Surgery. Position statement: sleeve gastrectomy as a bariatric procedure. SOARD. 2007;3:573–6.
27.
Zurück zum Zitat Lee CM, Cirangle PT, Jossart GH. Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results. Surg Endosc. 2007;21:1810–6.CrossRefPubMed Lee CM, Cirangle PT, Jossart GH. Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results. Surg Endosc. 2007;21:1810–6.CrossRefPubMed
28.
Zurück zum Zitat Flancbaum L, Belsky S. Factors affecting morbidity and mortality of Roux-en-Y gastric bypass for clinically severe obesity: an analysis of 1, 000 consecutive open cases by a single surgeon. J Gastrointest Surg. 2007;11:500–7.CrossRefPubMed Flancbaum L, Belsky S. Factors affecting morbidity and mortality of Roux-en-Y gastric bypass for clinically severe obesity: an analysis of 1, 000 consecutive open cases by a single surgeon. J Gastrointest Surg. 2007;11:500–7.CrossRefPubMed
29.
Zurück zum Zitat Jones KB, Afram JD, Benotti PN, et al. Open versus laparoscopic Roux-en-Y gastric bypass: a comparative study of over 25, 000 open cases and the major laparoscopic bariatric reported series. Obes Surg. 2006;16:721–7.CrossRefPubMed Jones KB, Afram JD, Benotti PN, et al. Open versus laparoscopic Roux-en-Y gastric bypass: a comparative study of over 25, 000 open cases and the major laparoscopic bariatric reported series. Obes Surg. 2006;16:721–7.CrossRefPubMed
30.
Zurück zum Zitat Shuhaiber J, Vitello J. Is gastric bypass associated with more complications in patients weighing >500 lbs? Obes Surg. 2004;14:42–6.CrossRef Shuhaiber J, Vitello J. Is gastric bypass associated with more complications in patients weighing >500 lbs? Obes Surg. 2004;14:42–6.CrossRef
31.
Zurück zum Zitat Jones KB. The double application of the TA-90B four-row stapler and pouch formation: eight rows are safe and effective in Roux-en-Y gastric bypass. Obes Surg. 1994;4:262–8.CrossRefPubMed Jones KB. The double application of the TA-90B four-row stapler and pouch formation: eight rows are safe and effective in Roux-en-Y gastric bypass. Obes Surg. 1994;4:262–8.CrossRefPubMed
32.
Zurück zum Zitat Jones KB, Homza W, Peavy PW, et al. Double application of the AT-90 B four-row AutoSuture stapling instrument: a safe effective method of staple-line production indicated by follow-up GI series. Obes Surg. 1996;6:494–9.CrossRefPubMed Jones KB, Homza W, Peavy PW, et al. Double application of the AT-90 B four-row AutoSuture stapling instrument: a safe effective method of staple-line production indicated by follow-up GI series. Obes Surg. 1996;6:494–9.CrossRefPubMed
33.
Zurück zum Zitat Jones KB. The superiority of the left subcostal incision compared to mid-line incisions in surgery for morbid obesity. Obes Surg. 1993;3:201–5.CrossRefPubMed Jones KB. The superiority of the left subcostal incision compared to mid-line incisions in surgery for morbid obesity. Obes Surg. 1993;3:201–5.CrossRefPubMed
Metadaten
Titel
Non-transectional Open Gastric Bypass as the Definitive Bariatric Procedure for 61 Patients with BMI of 70 and Higher
verfasst von
Gus J. Slotman
Publikationsdatum
01.01.2010
Verlag
Springer-Verlag
Erschienen in
Obesity Surgery / Ausgabe 1/2010
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-009-9991-7

Weitere Artikel der Ausgabe 1/2010

Obesity Surgery 1/2010 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.